Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.5K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.5K
Vaccinations01:51

Vaccinations

53.2K
Overview
53.2K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Humoral Immune Responses01:36

Humoral Immune Responses

85.5K
Overview
85.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic characterization and pathogenicity validation of Mycoplasma ovipneumoniae strains from diseased sheep: insights into potential pathogenic mechanisms of GSWW364.

Veterinary research·2026
Same author

Stage-adaptive integration of polydopamine promotes human pluripotent stem cell-derived alveolar organoids differentiation and maturation.

Materials today. Bio·2026
Same author

Comparison of Immunoprotective Efficacy of Six Antigenic Proteins of <i>Pasteurella multocida</i> Serotype a in KM Mice (<i>Mus musculus</i>).

Pathogens (Basel, Switzerland)·2026
Same author

Foot-and-mouth disease virus regulates glycolysis through autophagy to drive viral replication in vivo and in vitro.

Autophagy·2026
Same author

Exploring the Link Between Biotin Metabolism and <i>Brucella</i> Virulence: A Study on <i>BioA</i>.

Pathogens (Basel, Switzerland)·2026
Same author

Global Burden and Estrogenic Risk of Per- and Polyfluoroalkyl Substances in Cetaceans.

Environmental science & technology·2026

Related Experiment Video

Updated: Mar 14, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K

Haemophilus parasuis vaccines.

Huisheng Liu1, Qiao Xue1, Qiaoying Zeng1

  • 1Laboratory of Veterinary Microbiology, College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, China.

Veterinary Immunology and Immunopathology
|October 4, 2016
PubMed
Summary

Glässer

Keywords:
AdjuvantHaemophilus parasuisPigProgressVaccine

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.1K
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.5K

Related Experiment Videos

Last Updated: Mar 14, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.1K
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.5K

Area of Science:

  • Veterinary Medicine
  • Swine Health
  • Immunology

Background:

  • Glässer's disease, caused by Haemophilus parasuis, poses a significant global threat to swine populations.
  • Current control relies on inactivated vaccines with limitations, including lack of differentiation between infected and vaccinated animals and incomplete serovar coverage.
  • Novel vaccine strategies are needed to overcome the shortcomings of existing inactivated Haemophilus parasuis vaccines.

Purpose of the Study:

  • To review current knowledge on Haemophilus parasuis vaccines.
  • To identify limitations of existing inactivated vaccines.
  • To propose strategies for improving Haemophilus parasuis vaccine efficacy and applicability.

Main Methods:

  • Comprehensive literature review of Haemophilus parasuis vaccines.
  • Analysis of current vaccine limitations and challenges.
  • Synthesis of existing data to inform future vaccine development.

Main Results:

  • Existing inactivated Haemophilus parasuis vaccines fail to differentiate between infected and vaccinated animals.
  • Current vaccines do not cover all prevalent virulent serovars.
  • There is a lack of novel vaccine options addressing these deficiencies.

Conclusions:

  • Existing Haemophilus parasuis vaccines have significant limitations.
  • Improved vaccine strategies are crucial for effective Glässer's disease control.
  • Further research is needed to develop novel vaccines with broader coverage and diagnostic capabilities.